Promising Pre-clinical Data Supporting BerGenBio's Pipeline to be Published and Presented at Upcoming Leading Conferences |
| April 13, 2018 | April 2018 Bond Updates |
|
BERGEN, Norway, 13 April, 2018 /PRNewswire/ --
BerGenBio ASA (OSE: BGBIO) announces that promising pre-clinical data demonstrating that selective AXL inhibition counteracts the progression of aggressive fibrosis in the lung and liver has been published in the international... |
| View more at: https://www.prnewswire.com/news-releases/promising-pre-clinical-data-supporting-bergenbios-pipeline-to-be-published-and-presented-at-upcoming-leading-conferences-300629447.html |
| Related News |
|